Perrigo Company plc (PRGO)
NYSE: PRGO · IEX Real-Time Price · USD
-0.39 (-1.38%)
Jun 12, 2024, 4:00 PM EDT - Market closed

Perrigo Company Revenue

Perrigo Company had revenue of $4.56B in the twelve months ending March 30, 2024, down -0.07% year-over-year. Revenue in the quarter ending March 30, 2024 was $1.08B, a -8.43% decrease year-over-year. In the year 2023, Perrigo Company had annual revenue of $4.66B with 4.58% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
3.80B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 20234.66B204.00M4.58%
Dec 31, 20224.45B312.90M7.56%
Dec 31, 20214.14B50.50M1.24%
Dec 31, 20204.09B218.30M5.64%
Dec 31, 20193.87B-861.80M-18.21%
Dec 31, 20184.73B-214.50M-4.34%
Dec 31, 20174.95B-334.40M-6.33%
Dec 31, 20165.28B1.05B24.92%
Jun 27, 20154.23B313.00M8.00%
Jun 28, 20143.91B374.30M10.57%
Jun 29, 20133.54B366.60M11.55%
Jun 30, 20123.17B418.20M15.18%
Jun 25, 20112.76B486.85M21.46%
Jun 26, 20102.27B262.56M13.09%
Jun 27, 20092.01B275.67M15.94%
Jun 28, 20081.73B361.57M26.42%
Jun 30, 20071.37B1.53M0.11%
Jul 1, 20061.37B342.72M33.47%
Jun 25, 20051.02B125.89M14.02%
Jun 26, 2004898.20M64.10M7.69%
Jun 28, 2003834.10M-963.00K-0.12%
Jun 29, 2002835.06M81.58M10.83%
Jun 30, 2001753.49M9.20M1.24%
Jul 1, 2000744.28M-153.23M-17.07%
Jul 3, 1999897.52M-5.12M-0.57%
Jun 30, 1998902.64M58.05M6.87%
Jun 30, 1997844.59M66.47M8.54%
Jun 30, 1996778.12M61.04M8.51%
Jun 30, 1995717.08M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Oscar Health 6.54B
Alkermes 1.73B
Integer Holdings 1.63B
Neogen 929.24M
Guardant Health 603.73M
Ultragenyx Pharmaceutical 442.59M
Merus 38.34M
Crinetics Pharmaceuticals 1.97M
Revenue Rankings